Bachem Holding AG
BANB
株式のランク
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
株価
$100.60
時価総額
$7.54B
変化（1日）
-1.49%
変化（1年）
49.53%
国
CH
取引 Bachem Holding AG (BANB)
カテゴリー
Healthcare
Bachem Holding AG（BANB）の発行済株式数
October 2026 時点の発行済株式数 0
Bachem Holding AG の最新の財務報告および株価によると、現在の発行済株式数は 0 です。October 2026 の終わりには、同社は 0 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Bachem Holding AG（BANB）の発行済株式数の履歴（2002 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2025 | 74.96M | -0.02% |
| 2024 | 74.98M | 0.39% |
| 2023 | 74.69M | 1.29% |
| 2022 | 73.73M | 4.08% |
| 2021 | 70.85M | 1.23% |
| 2020 | 69.99M | 1.16% |
| 2019 | 69.18M | 1.86% |
| 2018 | 67.92M | 0.09% |
| 2017 | 67.86M | 0.19% |
| 2016 | 67.73M | 0.10% |
| 2015 | 67.66M | 0.14% |
| 2014 | 67.57M | 0.10% |
| 2013 | 67.50M | 0.08% |
| 2012 | 67.45M | 0.13% |
| 2011 | 67.37M | 0.06% |
| 2010 | 67.33M | 0.14% |
| 2009 | 67.23M | 0.28% |
| 2008 | 67.04M | 0.95% |
| 2007 | 66.41M | 0.70% |
| 2006 | 65.95M | 0.04% |
| 2005 | 65.93M | -0.16% |
| 2004 | 66.03M | -0.34% |
| 2003 | 66.26M | -0.56% |
| 2002 | 66.63M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| - | - |
CH
|
